BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21529740)

  • 1. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.
    Sarma A; Cannon CP; de Lemos J; Rouleau JL; Lewis EF; Guo J; Mega JL; Sabatine MS; O'Donoghue ML
    J Am Heart Assoc; 2014 May; 3(3):e000784. PubMed ID: 24786143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes.
    Beirne AM; Mitchelmore O; Palma S; Andiapen M; Rathod KS; Hammond V; Bellin A; Cooper J; Wright P; Antoniou S; Yaqoob MM; Naci H; Mathur A; Ahluwalia A; Jones DA
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):303-309. PubMed ID: 33764198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Jones DA; Beirne AM; Kelham M; Wynne L; Andiapen M; Rathod KS; Parakaw T; Adams J; Learoyd A; Khan K; Godec T; Wright P; Antoniou S; Wragg A; Yaqoob M; Mathur A; Ahluwalia A
    Eur Heart J; 2024 May; 45(18):1647-1658. PubMed ID: 38513060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.
    Li H; Li X; Ma H; Wang Y; Fu N; Jin D; Cong H
    ScientificWorldJournal; 2014; 2014():565367. PubMed ID: 24672331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins.
    Subramanian S; Emami H; Vucic E; Singh P; Vijayakumar J; Fifer KM; Alon A; Shankar SS; Farkouh M; Rudd JHF; Fayad ZA; Van Dyke TE; Tawakol A
    J Am Coll Cardiol; 2013 Dec; 62(25):2382-2391. PubMed ID: 24070911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for contrast induced nephropathy: a study among Italian patients.
    Evola S; Lunetta M; Macaione F; Fonte G; Milana G; Corrado E; Bonura F; Novo G; Hoffmann E; Novo S
    Indian Heart J; 2012; 64(5):484-91. PubMed ID: 23102387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial.
    Gholoobi A; Sajjadi SM; Shabestari MM; Eshraghi A; Shamloo AS
    Electron Physician; 2015 Dec; 7(8):1557-65. PubMed ID: 26816582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trials.
    Lee JM; Park J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Jo SH; Kim HS
    PLoS One; 2014; 9(11):e111397. PubMed ID: 25369120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-urea-nitrogen-to-serum-albumin ratio in predicting the value of patients with contrast-induced nephropathy for coronary heart disease.
    Pan Q; Peng Y; Ni H; Lin L; Luo B; Huang X; Chen L; Lin Y
    Int Urol Nephrol; 2024 Jun; 56(6):2075-2083. PubMed ID: 38281310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial to assess the potential role of ascorbic acid and statin for post-contrast acute kidney injury prevention.
    Hashem A; Laymon M; Elgamal M; Hegazy M; Elmeniar AM; Refaie H; Osman Y
    Int Urol Nephrol; 2024 Feb; 56(2):399-405. PubMed ID: 37742328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Randomized Trial of Na/K Citrate for the Prevention of Contrast-Induced Nephropathy in High-risk Patients.
    Iranirad L; Sadeghi MS; Hejazi SF
    Med J Islam Repub Iran; 2024; 38():27. PubMed ID: 38783979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy.
    Kabeer MA; Cross J; Hamilton G; Rashid ST
    Angiology; 2021 Mar; 72(3):274-278. PubMed ID: 33228378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone for Preventing Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease.
    Lu Y; Ni W; Qu X; Chen C; Shi S; Guo K; Lin K; Zhou H
    Angiology; 2024 Apr; ():33197241251889. PubMed ID: 38679489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention.
    He GX; Tan W
    J Geriatr Cardiol; 2013 Dec; 10(4):355-60. PubMed ID: 24454329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-Induced Nephropathy in Interventional Cardiology: Incidence, Risk Factors, and Identification of High-Risk Patients.
    Shuka N; Hasimi E; Kristo A; Simoni L; Gishto T; Shirka E; Zaimi Petrela E; Goda A
    Cureus; 2023 Dec; 15(12):e51283. PubMed ID: 38288173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization.
    Kumar A; Bhawani G; Kumari N; Murthy KS; Lalwani V; Raju ChN
    J Clin Diagn Res; 2014 Dec; 8(12):HC03-7. PubMed ID: 25653965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Contrast-induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention.
    Pranata R; Wahyudi DP
    Curr Cardiol Rev; 2023 Oct; 20(1):. PubMed ID: 37877506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.
    Andreucci M; Solomon R; Tasanarong A
    Biomed Res Int; 2014; 2014():741018. PubMed ID: 24895606
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.